Daniel Alkon

(DR. Daniel Alkon M.D.)

Currently holds positions in Synaptogenix Inc and Neurotrope Inc

Positions

Position Company Period
Chief Scientific Officer Synaptogenix Inc None -
President, Chief Scientific Officer Neurotrope Inc Sept. 23, 2016 -
Chief Scientific Officer Neurotrope Inc Aug. 1, 2013 - Sept. 23, 2016
Daniel Alkon's trades of Synaptogenix Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-12-20 2022-12-16
PS Planned sale
19,688 -35.6%
1.17
USD 23,072 		19,688 -35.6% 1.17 USD 23,072
2021-06-16 2021-06-14
B Purchase
10,000 +673.9%
8.26
USD 82,600 		10,000 +673.9% 8.26 USD 82,600
// ... existing code ... // ... rest of the file ...